149 related articles for article (PubMed ID: 6393384)
21. Allogeneic bone marrow transplantation from a related donor undergoing long-term immunosuppressive and cytotoxic therapy.
Adams GB; Lipton JH; Jamal N; Messner HA
Bone Marrow Transplant; 1994 Jun; 13(6):831-3. PubMed ID: 7920323
[TBL] [Abstract][Full Text] [Related]
22. Mild pre-transplant cardiomyopathy may not impair long-term quality of life after bone marrow transplantation.
Nicolini B; Balduzzi A; Tagliabue A; Longoni D; Uderzo C; Galli MA
Bone Marrow Transplant; 2000 Feb; 25(3):335-6. PubMed ID: 10673709
[TBL] [Abstract][Full Text] [Related]
23. Acquired ichthyosis in bone marrow transplant recipients.
Spelman LJ; Strutton GM; Robertson IM; Weedon D
J Am Acad Dermatol; 1996 Jul; 35(1):17-20. PubMed ID: 8682957
[TBL] [Abstract][Full Text] [Related]
24. Near-tetraploid acute myeloid leukemia after allogeneic bone marrow transplantation.
Laurenti L; d'Onofrio G; Zini G; Sica S; Chiusolo P; Leone G
Haematologica; 2000 Apr; 85(4):432-4. PubMed ID: 10756374
[No Abstract] [Full Text] [Related]
25. Bone-marrow transplantation in chronic myelogenous leukemia.
Jackson SJ; Jarolim DR
N Engl J Med; 1982 Jun; 306(22):1364-5. PubMed ID: 7040972
[No Abstract] [Full Text] [Related]
26. Bone marrow transplantation in acute leukemia.
Santos GW; Kaizer H
Semin Hematol; 1982 Jul; 19(3):227-39. PubMed ID: 7051290
[No Abstract] [Full Text] [Related]
27. Bone marrow transplantation in leukemia.
Gale RP
Ann Clin Res; 1981; 13(4-5):367-72. PubMed ID: 7039488
[TBL] [Abstract][Full Text] [Related]
28. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
[TBL] [Abstract][Full Text] [Related]
29. Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies.
Malladi RK; Peniket AJ; Norton AE; Campbell AJ; Collins GP; Samol J; Eagleton H; Miller E; Morgenstern G; Jones J; Keen-Mcguire A; Barnardo M; Littlewood TJ
Eur J Haematol; 2004 Aug; 73(2):85-92. PubMed ID: 15245506
[TBL] [Abstract][Full Text] [Related]
30. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis.
Fagioli F; Bacigalupo A; Frassoni F; Van Lint MT; Occhini D; Gualandi F; Lamparelli T; Clavio M; Vitale V; Sogno G
Bone Marrow Transplant; 1994 Mar; 13(3):247-52. PubMed ID: 8199567
[TBL] [Abstract][Full Text] [Related]
32. Isolated extramedullary relapse in the pleural fluid of a patient with acute myeloid leukemia following allogeneic BMT.
Park J; Park SY; Cho HI; Lee D
Bone Marrow Transplant; 2002 Jul; 30(1):57-9. PubMed ID: 12105780
[TBL] [Abstract][Full Text] [Related]
33. [New prospects in the treatment of chronic myeloid leukemia and evaluation of present therapeutic procedures].
Chrobák L
Vnitr Lek; 1981 Apr; 27(4):392-400. PubMed ID: 7027605
[No Abstract] [Full Text] [Related]
34. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
[TBL] [Abstract][Full Text] [Related]
35. Outcome of autologous rescue after failed engraftment of allogeneic marrow.
Mehta J; Powles R; Singhal S; Horton C; Treleaven J
Bone Marrow Transplant; 1996 Feb; 17(2):213-7. PubMed ID: 8640169
[TBL] [Abstract][Full Text] [Related]
36. Partially mismatched related donor bone marrow transplantation as salvage for patients with AML who failed autologous stem cell transplant.
Godder KT; Mehta J; Chiang KY; Adams S; van Rhee F; Singhal S; Higgins-Smith K; O'Neal W; DeRienzo S; Henslee-Downey JP
Bone Marrow Transplant; 2001 Dec; 28(11):1031-6. PubMed ID: 11781612
[TBL] [Abstract][Full Text] [Related]
37. Autologous bone marrow transplantation for acute myeloid leukemia.
Imrie K; Dicke KA; Keating A
Stem Cells; 1996 Jan; 14(1):69-78. PubMed ID: 8820953
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow transplantation in Canada.
Buskard NA
Can Med Assoc J; 1980 Jul; 123(1):19-22. PubMed ID: 6998551
[TBL] [Abstract][Full Text] [Related]
39. [Is leukemic transformation of donor cells possible?].
Vinogradova OA; Savchenko VG; Domracheva EV; Parovichnikova EN; Diachenko LV; Alimova GA; Mendeleeva LP; Liubimova LS; Sokolov AN; Zhelnova EI; Pokrovskaia OS
Ter Arkh; 2004; 76(7):28-34. PubMed ID: 15379124
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
